The Role of Artificial Intelligence in Managing Multimorbidity and Cancer

Author:

Cesario AlfredoORCID,D’Oria MarikaORCID,Calvani RiccardoORCID,Picca AnnaORCID,Pietragalla AntonellaORCID,Lorusso Domenica,Daniele Gennaro,Lohmeyer Franziska Michaela,Boldrini LucaORCID,Valentini Vincenzo,Bernabei Roberto,Auffray Charles,Scambia Giovanni

Abstract

Traditional healthcare paradigms rely on the disease-centered approach aiming at reducing human nature by discovering specific drivers and biomarkers that cause the advent and progression of diseases. This reductive approach is not always suitable to understand and manage complex conditions, such as multimorbidity and cancer. Multimorbidity requires considering heterogeneous data to tailor preventing and targeting interventions. Personalized Medicine represents an innovative approach to address the care needs of multimorbid patients considering relevant patient characteristics, such as lifestyle and individual preferences, in opposition to the more traditional “one-size-fits-all” strategy focused on interventions designed at the population level. Integration of omic (e.g., genomics) and non-strictly medical (e.g., lifestyle, the exposome) data is necessary to understand patients’ complexity. Artificial Intelligence can help integrate and manage heterogeneous data through advanced machine learning and bioinformatics algorithms to define the best treatment for each patient with multimorbidity and cancer. The experience of an Italian research hospital, leader in the field of oncology, may help to understand the multifaceted issue of managing multimorbidity and cancer in the framework of Personalized Medicine.

Publisher

MDPI AG

Subject

Medicine (miscellaneous)

Reference67 articles.

1. Blind men and Elephant https://commons.wikimedia.org/w/index.php?curid=4581263

2. Putting the Patient Back Together — Social Medicine, Network Medicine, and the Limits of Reductionism

3. Promise of personalized omics to precision medicine

4. Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease,2011

5. Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3